<DOC>
	<DOCNO>NCT01526278</DOCNO>
	<brief_summary>This study evaluate clinical safety pharmacokinetics Maxmarvil® healthy postmenopausal woman</brief_summary>
	<brief_title>Pharmacokinetics Maxmarvil® Healthy Postmenopausal Women</brief_title>
	<detailed_description>Pharmacokinetics single Oral Dose Maxmarvil® healthy postmenopausal woman without previous history fracture 1. evaluation Pharmacokinetics - Urine collection : Pre-dose ( pre 1hour ) , post-dose 0~6 hour , 6~12 hour , 12~24 hour - Evaluation Variables : Aet 2 . Evaluation safety , pharmacodynamics - Adverse Event : check every frequently - Physical exam : screening , injection , post-dose 24 hour post-study visit - Vital sign : screening , injection , post-dose 1 hour , 24 hour post-study visit - Laboratory test : screening , post-dose 24hour</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<criteria>Screening test healthy postmenopausal woman without previous history fracture Normal range laboratory test arrange principal investigator character medicine 50kg , body weight ± 20 % ideal body weight Written concent follow protocol understand explain clinical trial Subject take something induce inhibit drug metabolize enzyme within 1 month like Barbiturate . Subject history drug abuse get positive urine test drug abuse . Subject take prescription medicine oriental medicine within 2 week first administration clinical drug trial , take OTC within 1 week first administration clinical drug trial like OTC include calcium , antacid , multiple vitamin , mineral . Subject chronic drinking ( 21 units/week ) stop drink clinical trial . Subject smoke 10 unit/day 3months . Subject light clear hypersensitivity reaction OTC ( aspirin , antibiotic medication ) bisphosphonates ( alendronate ) Subject get disease liver , kidney , neurology , respiratory , endocrine , hematooncology , cardiovascular , musculoskeletal , psychological history fracture within 12months tooth extraction within 6month Subject history gastrointestinal disease stomach surgery without appendectomy , herniotomy effort absorb clinical drug trial . Subject esophageal disease like esophagitis , esophageal ulcer , esophagus erosion , esophagorrhaphy , esophagostenosis , dysphagia . Subject keep sit position 30minutes Subject normal range calcium concentration blood ( 8.8 ~ 10.5 mg/dl ) Subject hypotension ( systolic blood pressure ≤ 90mmHg diastolic blood pressure ≤ 50 mmHg ) hypertension ( systolic blood pressure ≥ 150mmHg diastolic blood pressure ≥ 100 mmHg ) sit position rest 3 minute join clinical trial within 2months administration clinical drug trial . Subject donated whole blood within 2 month plasma within 1 month . Subject grapefruit something include caffeine close season ( 3 day administration discharge hospital ) For result laboratory reason subject consider unsuitable principal 's decision</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>alendronate</keyword>
	<keyword>Maxmarvil®</keyword>
</DOC>